U.S. Acellular Dermal Matrices Market, By Origin (Human Dermis, Porcine Dermis, Bovine Dermis), By Application (Acute Wounds (Burns, Trauma, Cancers, Infections) Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcer, Others), Reconstruct

U.S. Acellular Dermal Matrices Market, By Origin (Human Dermis, Porcine Dermis, Bovine Dermis), By Application (Acute Wounds (Burns, Trauma, Cancers, Infections) Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcer, Others), Reconstruction Procedures (Abdominal Wall Procedures, Breast Procedures, Orthopedic Procedures, Others), By Place of Setting (Hospitals, Ambulatory Surgical Centers, Office Based) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Acellular dermal matrices refer to biologically derived products that are devoid of cells. Generally, these matrices are derived from many sources including porcine, human, and bovine. Elastic fibers and collagen are some of the key components of acellular dermal matrices. In the recent past, there has been a remarkable growth in the application of acellular dermal matrices in plastic surgery, cosmetic surgery, breast reconstruction, and wound healing procedures.
Decellularized dermal tissue or acellular dermal matrix (ADM) can be derived from human dermis from which the cellular components such as keratinocytes, sweat glands, sebaceous glands, fibroblasts, vascular endothelium, and smooth muscles are removed or extracted. Porcine and human dermis are decellularized by first removing the epidermis by incubating the skin in 1 M sodium chloride (NaCl) at 37 °C for 8 hours. Dermal fibroblast and epithelial cells are then removed by incubating the material in 2% sodium deoxycholate containing 10 mM (Millimeter) Ethylenediaminetetraacetic acid (EDTA) at room temperature overnight. The dermis is then cryoprotected with a combination of 35% maltodextrin and 10 mM disodium-EDTA, and packaged as a freeze-dried sheet until it is rehydrated at the time of surgery.
Market Dynamics
The increased number of plastic surgeries, cosmetic surgeries, breast reconstruction surgeries, and wound healing procedures are expected to drive the growth of global acellular dermal matrices market over the forecast period. According to the American Society of Plastic Surgeons 2019 report, 299,715 breast augmentation surgeries, 265,209 liposuctions, 181,132 scar revision surgeries were performed in the U.S. along with 9,117 cosmetic surgeries using acellular dermal matrices.
Key features of the study:
This report provides in-depth analysis of the global acellular dermal matrices market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global acellular dermal matrices market based on the following parameters – Company Highlights, Types Portfolio, Key Highlights, Financial Performance, and Market Strategies.
Key companies covered as a part of this study include Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acellular dermal matrices market
Detailed Segmentation:
Global Acellular Dermal Matrices Market, By Origin:
Human Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Porcine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Bovine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Global Acellular Dermal Matrices Market, By Application:
Acute Wounds
Burns
Trauma
Cancers
Infections
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcer
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Reconstruction Procedures
Abdominal Wall Procedures
Breast Procedures
Orthopedic Procedures
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Global Acellular Dermal Matrices Market, By Place of Setting:
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Global Acellular Dermal Matrices Market, By Region:
North America
By Origin
Human Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Porcine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Bovine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Application
Acute Wounds
Burns
Trauma
Cancers
Infections
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcer
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Reconstruction Procedures
Abdominal Wall Procedures
Breast Procedures
Orthopedic Procedures
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Place of Setting
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Country
U.S.
Canada
Latin America
By Origin
Human Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Porcine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Bovine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Application
Acute Wounds
Burns
Trauma
Cancers
Infections
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcer
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Reconstruction Procedures
Abdominal Wall Procedures
Breast Procedures
Orthopedic Procedures
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Place of Setting
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Origin
Human Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Porcine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Bovine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Application
Acute Wounds
Burns
Trauma
Cancers
Infections
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcer
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Reconstruction Procedures
Abdominal Wall Procedures
Breast Procedures
Orthopedic Procedures
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Place of Setting
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Origin
Human Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Porcine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Bovine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Application
Acute Wounds
Burns
Trauma
Cancers
Infections
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcer
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Reconstruction Procedures
Abdominal Wall Procedures
Breast Procedures
Orthopedic Procedures
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Place of Setting
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Origin
Human Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Porcine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Bovine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Application
Acute Wounds
Burns
Trauma
Cancers
Infections
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcer
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Reconstruction Procedures
Abdominal Wall Procedures
Breast Procedures
Orthopedic Procedures
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Place of Setting
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Country
GCC
Israel
Rest of Middle East
Africa
By Origin
Human Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Porcine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Bovine Dermis
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Application
Acute Wounds
Burns
Trauma
Cancers
Infections
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcer
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
Reconstruction Procedures
Abdominal Wall Procedures
Breast Procedures
Orthopedic Procedures
Others
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Place of Setting
Hospitals
In- patient
Out- patient
Ambulatory Surgical Centers
Office Based
By Country
South Africa
Central Africa
North Africa
Company Profiles
Integra LifeSciences Corporation
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
AbbVie Inc.
Johnson & Johnson
HansBioMed
Becton, Dickinson and Company
Cook Group
Smith & Nephew Plc.
Reprise Biomedical
Organogenesis Holdings Inc.
Tissue Regenix
LifeNet Health
Zimmer Biomet Holdings, Inc.
Stryker Corporation
MiMedx Group
PolyNovo Limited
Fidia Pharma USA Inc.
Baxter International Inc.
In2Bones Global
BioHorizons, Inc.
Harbor MedTech, Inc.
MLM Biologics Inc.
Geistlich Pharma AG
Olaregen Therapeutix, Inc.
EnColl Corporation
Kerecis limited
DSM
ACell Inc.
3M
Cell Constructs I, LLC
CG bio Inc.
Marine Polymer Technologies, Inc.
“*” marked represents similar segmentation in other categories in the respective section.